American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

May 20, 2022

Newsletter Sponsor

Proprietary Nanotechnologies

Ascendia Pharmaceuticals is a specialty CDMO that has developed three proprietary nanotechnologies for all sterile and non-sterile biologics and small molecule formulations. NanoSol^®, EmulSol^®, and AmorSol^® are used to deliver sophisticated formulations to enhance bioavailability and solubility. The unique dosage forms created by Ascendia can be administered orally, topically, injection, ophthalmic, inhalation, and LAI.

	Industry News

Rafael Pharmaceuticals Changes Name to Cornerstone Pharmaceuticals
Rafael Pharmaceuticals, Inc. announced that it is changing its name to Cornerstone Pharmaceuticals, ... read more »

EMA Receives Marketing Authorization Application for Valneva’s COVID-19 Vaccine
Valneva SE has confirmed that the European Medicines Agency (“EMA”) has accepted the filing of a ... read more »

FDA Issues Guidance on Safety Considerations for Container Labels to Minimize Medication Errors
FDA has issued the final guidance titled “Safety Considerations for Container Labels and Carton ... read more »

Pfizer and BioNTech Granted U.S. EUA for Booster Dose of Their COVID-19 Vaccine in Children
Pfizer Inc. and BioNTech SE announced the U.S. Food and Drug Administration (FDA) expanded emergency... read more »

	QC Corner

QC Corner: Environmental Monitoring as a Component of a Contamination Control Strategy
Watch Now! In this webinar, Mark Hallworth discusses environmental monitoring as a component of a ... read more »

	Featured Articles

Using Slope Spectroscopy® to Streamline Development for AAV Titer Determination Processes Today, one of the primary challenges in the production of consistent quality of recombinant adeno-associated virus (rAAV) remains the fact that ... read more »

Will We Still Need Quality Management by 2025? What influences the way life sciences companies manage Quality today – and what does the future hold for the discipline as smart automation presents ... read more »

	Featured Video

On-Demand Webinar: Modeling Inflammatory Immune Cell Recruitment and Response with the Colon Intestine-Chip
Join this webinar to learn how you can use the Colon Intestine-Chip to develop more effective, targeted therapeutic strategies for IBD across an ... watch »

On-Demand Webinar: Back to Basics: Growth Promotion Testing
In this webinar you’ll learn the rules for performing growth promotion testing, why we perform growth promotion testing and best practices. watch »

	Featured Products

Remote Particle Counter: IsoAir® Pro-Plus
read more »

Discovery DSC 2500
read more »

Sievers M9 TOC Analyzers
read more »

	Featured Whitepaper

App Note: Cubis® II Lab Balance in the Context of Therapeutic Antibodies
Antibodies are subject to instability issues due to chemical and physical instabilities. Oxidation, disulfide bond formation, Glycation and Deamidation are the most frequent chemical instabilities ... read more »

eBook: Analytical Method and QC Testing Strategies for Biologics Production
Development of a manufacturing process for a biotherapeutic that ensures consistent quality, purity and safety is a critical step in successfully developing the drug, getting it approved by regulatory... read more »

	Events

ASMS Conference
Minneapolis, Minnesota – 06/05/2022
The 70th ASMS Conference on Mass Spectrometry and Allied Topics (ASMS 2022) will take place 5-9 June 2022 in Minneapolis, MN, USA. The annual ... event details »

Controlled Release Society 2022
Montreal, Canada – 07/11/2022
CRS is the home for experts dedicated to delivery science, including delivery scientists, engineers, clinicians, and technical professionals. CRS ... event details »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
164 Townsend St. Unit 2
San Francisco, CA 94107 USA